📌 Key Takeaways
- Topic: What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
- Keywords: monocrystalline silicon
- Published: 2026-11-20 05:43:50
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Free Flow Agent: Typical Dosage, Benefits and Best Grades
- Silica Supplier Germany: Leading Producers and Sourcing Considerations
- Wu, S. et al. Bacterial outer membrane‐coated mesoporous silica nanoparticles for targeted delivery of antibiotic rifampicin against Gram‐negative bacterial infection in vivo. Adv. Funct. Mater. 31, 2103442 (2021). Article CAS Google Scholar
- Silica as an Insulating Filler: Dielectric Properties and Electronic Uses
- Silica as a Moisture Absorber: How It Works and How Much You Need
- Xu, B. et al. Immunomodulation‐enhanced nanozyme‐based tumor catalytic therapy. Adv. Mater. 32, 2003563 (2020). Article CAS Google Scholar
- Silica as an Abrasive: Hardness, Particle Size and Applications
Silica as a Thixotropic Agent: Mechanism, Dosage and Applications
What is silica (SiO₂)?
is silicon dioxide toxic
What is the difference between fumed silica and precipitated silica?
silicon dioxide in supplements
What drives silica raw material prices?
colloidal silicon dioxide excipient MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.